The nanoPET/CT dual-modality Preclinical Imager transforms researchers’ ability to use PET to study the absorption, distribution,
metabolism and excretion characteristics of candidate molecules with fast assay kinetics. The NanoPET/CT’s PET detector comprises
twelve detector arrays of 85x39 LYSO crystals which provides the best spatial resolution available in the market today—less
than 1.2mm at CFOV. The superior performance of the NanoPET/CT will enable you to image animals as small as mice and rats with
the same visual acuity as humans.
NanoSPECT/CT is a revolutionary Small-Animal Imager that achieves unparalleled performance in the field of Nuclear Molecular Imaging. This
dual-modality Preclinical Imager is dramatically altering the way researchers utilize animal models to study mechanisms of disease,
its progression and its response to a therapeutic intervention. NanoSPECT uses patented Multiplexed Multi-Pinhole (MMP) SPECT technology
which increases imaging sensitivity ten-fold. In addition to the optional high resolution CT x-ray system, the NanoSPECT also
offers the optional Minerve Small-AnimalEnvironment System which provides critical support functions to lab animals during the
preparation stage, and throughout the imaging process.
See the results obtained so far from leading researchers around the world that prove
Bioscan
are taking preclinical molecular imaging to a new level of performance!
(Visitwww.spect-ct.com)